The Cascade Report

DENTAL CARE ALLIANCE
$1.1 Billion in Debt, Gone

Dental Care Alliance (DCA), which operates over 400 dental practices across 24 states, completed an out-of-court financial restructuring in June 2026 that eliminated $1.1 billion in debt and secured $95 million in new capital.

DCA had been carrying debt accumulated through years of rapid acquisition. At its peak, the

organization was adding dozens of locations per year under its multi-brand portfolio model. The restructuring was negotiated directly with creditors, avoiding a formal bankruptcy filing.

DCA chose an out-of-court restructuring rather than a formal Chapter 11 filing. That signals an organization that recognized the problem before it became a crisis and had enough operational value to convince creditors that continued operation was preferable to liquidation.

DCA's statement emphasized a refocus on "operational excellence and sustainable growth." That language would have been unusual two years ago when the playbook was add locations, increase top-line revenue, and refinance

AFFORDABLE CARE
Equity Holders Wiped Out

The Affordable Care story is more severe. The company, which operates approximately 425 dental practices, was owned by Harvest Partners (which acquired it from Berkshire Partners in 2021 for roughly $2.7 billion) and carried $1.4 billion in private credit debt from lenders including Blackstone and KKR.

In its restructuring, that $1.4 billion was slashed by roughly 70 percent. Blackstone and KKR converted their remaining debt positions into equity, effectively taking control of the company. Previous equity holders, including Harvest Partners, were wiped out entirely.

Unlike DCA's controlled out-of-court process, Affordable Care's restructuring represents a more dramatic shift in ownership and control. When private credit lenders become equity owners, the incentive structure changes. The new operators are primarily focused on protecting the remaining value of their converted debt positions rather than on growth.

This matters because Affordable Care is one of the largest dental platforms in the country. How it operates going forward will likely influence how PE firms approach dental acquisitions broadly.

The Pattern Behind the Numbers

DCA and Affordable Care are not isolated cases. They represent the inevitable conclusion of a specific growth model: acquire aggressively with leveraged capital, assume scale will drive margin expansion, and plan to refinance or exit before debt service becomes unmanageable.

That model works when interest rates are low and credit markets are liquid. Since those conditions have changed, the math breaks. The platforms carrying the most debt relative to their actual operating earnings are the ones most exposed. We should expect additional restructurings in the coming 12 to 18 months.

What This Means for Your Practice
If You're Considering a Sale
Despite the restructuring headlines, buyer demand for well-run practices has not disappeared. What has changed is the terms.

DCA just raised $95 million in new capital. Other platforms continue to acquire. But the buyers getting funded right now are the disciplined ones. They're underwriting based on actual EBITDA, not pro forma projections or adjusted EBITDA assumptions.

Practices with clean financials and clear operational workflows will command premium multiples. Practices that can't produce a reliable trailing- twelve-months P&L will have fewer options.

If You're Staying Independent
The best thing you can take from this moment is not to fear consolidation. Across the board, the practices that survive these types of market corrections are the ones that never needed outside capital in the first place. Just keep doing what you know will consistently help your practice find success time and time again.

Efficient practice workflows, strong case acceptance, and a team that works well together without your hour by hour oversight.

The bottom line?
The debt-fueled growth era isn't over. But it has definitely changed.
Practices that run lean, document well, and produce real earnings have more leverage now than at any point in the last five years. Use it

I can walk into any orthodontic practice and tell you within 20 minutes whether the team runs the day or the doctor does. It shows up in small things. Is the treatment coordinator presenting treatment plans and handling financial conversations on her own, or is she waiting for the doctor to come close every case? Does the front desk know what to do when the schedule blows up at 2 p.m., or does everyone freeze until someone asks the doctor what to do? When the doctor steps out of the room, does the day keep moving?

In most practices, the answer is no. And that is the single biggest operational problem in orthodontics right now. Not technology, not marketing, not insurance reimbursement. The problem is that most practices are built entirely around the doctor instead of around repeatable systems that anyone on the team can follow.

Here is what you can do about it, starting Monday morning.

Document your top 10 workflows. Scheduling, new patient intake, treatment coordination, insurance verification, same-day starts, financial presentations, recall and follow-up, records appointments, emergency visits, and end of-day closeout. Write down exactly how each one should be done, step by step, so that any trained team member can follow the process without asking someone else. If the only person who knows how insurance verification works is Sarah, and Sarah leaves, you do not have a system. You have a single point of failure.

Train your TC to own the case acceptance conversation. Your treatment coordinator should be able to present treatment, walk through financial options, and handle objections without waiting for you to step in and close. That does not mean the doctor is uninvolved. It means the doctor's role is clinical and the TC's role is conversion. If you are the one closing every case, you are the bottleneck, and your case acceptance rate will always be limited by your availability.

Run a weekly 15-minute team huddle focused on one metric. Pick one number each week: starts, case acceptance rate, collections, or outstanding AR. Review it as a team. Talk about what moved it and what did not. This is not a staff meeting. It is 15 minutes with a single focus so your team is tracking outcomes rather than just showing up and going through the motions.

Build redundancy into every critical role. Ask yourself this question: if one person on your team leaves tomorrow, can someone else step into that role and keep things running? If the answer is no, that is your biggest vulnerability. Cross-train your team so that no single absence can shut down a function. This is especially true for your front desk and your TC, the two roles where turnover hits the hardest.

Let your lead assistant run morning huddle. Let your TC own the entire follow-up process from consult to contract. Let your scheduling coordinator make real-time decisions about the schedule without checking with you first. People stay at jobs where they feel like their work matters and where they have real authority over their domain. If every decision routes through the doctor, your best people will eventually leave for somewhere that trusts them more.

The DSO restructurings in this issue happened at the corporate level, but the operational lesson applies everywhere. The practices that never need outside capital are the ones where the team produces consistent results whether the doctor is in the room or not.

The best thing you can take from this moment is not to fear consolidation. Across the board, the practices that survive these types of market corrections are the ones that never needed outside capital in the first place. Just keep doing what you know will consistently help your practice find success time and time again.

Efficient practice workflows, strong case acceptance, and a team that works well together without your hour by hour oversight.

The European Commission has opened a formal antitrust investigation into Align Technology, the maker of Invisalign and the iTero intraoral scanner. This is the first EU antitrust probe ever directed at a medical device company.

The investigation centers on whether Align has been tying its iTero scanner to the Invisalign system since 2017, effectively restricting which scanners can be used with Invisalign treatments and limiting competition in the scanner market.

The accusation: since acquiring iTero, Align has made it increasingly difficult, or outright impractical, for competing scanners to integrate seamlessly with Invisalign's treatment planning and submission workflow. If the scanner doesn't talk to ClinCheck, the clinical workflow breaks.

Why This Matters for U.S. Practices
EU enforcement actions have a way of reshaping global product strategy. If the Commission rules against Align, the company may be required to open its ecosystem to competing scanners. That move would benefit practices looking for scanner flexibility without sacrificing their Invisalign workflow.

It could also accelerate the "open ecosystem" movement already underway in orthodontic software, where practices are pushing for interoperability between different aligner brands, scanners, and practice management systems.

The Allegation
Align has tied iTero scanners to the Invisalign system since 2017, restricting competing scanners. The EU is investigating whether this constitutes abuse of a dominant market position under Article 102 of the Treaty on the Functioning of the European Union.